Publications (22) MARIA ANGELES SOLINIS ASPIAZU publications

filter_list Bioengineering

2024

  1. Gene therapy with lipid nanoparticles for Fabry disease: Leveraging E-selectin for targeted delivery to endothelial cells

    Journal of Drug Delivery Science and Technology, Vol. 99

2022

  1. Galactomannan-Decorated Lipidic Nanocarrier for Gene Supplementation Therapy in Fabry Disease

    Nanomaterials, Vol. 12, Núm. 14

2021

  1. Functionalised SLNs-based nanovectors for gene therapy in Fabry disease: The liver as an α-Galactosidase A factory

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 46-48

  2. Mrna-based nanomedicinal products to address corneal inflammation by interleukin-10 supplementation

    Pharmaceutics, Vol. 13, Núm. 9

2019

  1. MMP-9 downregulation with lipid nanoparticles for inhibiting corneal neovascularization by gene silencing

    Nanomaterials, Vol. 9, Núm. 4

2016

  1. Applications of lipid nanoparticles in gene therapy

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 109, pp. 184-193

  2. Silencing of hepatitis C virus replication by a non-viral vector based on solid lipid nanoparticles containing a shRNA targeted to the internal ribosome entry site (IRES)

    Colloids and Surfaces B: Biointerfaces, Vol. 146, pp. 808-817

2015

  1. Solid lipid nanoparticles as non-viral vector for the treatment of chronic hepatitis C by RNA interference

    International Journal of Pharmaceutics, Vol. 479, Núm. 1, pp. 181-188

  2. Solid lipid nanoparticles as non-viral vectors for gene transfection in a cell model of fabry disease

    Journal of Biomedical Nanotechnology, Vol. 11, Núm. 3, pp. 500-511

2014

  1. Development of nucleic acid vaccines: Use of self-amplifying RNA in lipid nanoparticles

    International Journal of Nanomedicine, Vol. 9, Núm. 1, pp. 1833-1843

  2. Fate of nanostructured lipid carriers (NLCs) following the oral route: Design, pharmacokinetics and biodistribution

    Journal of Microencapsulation, Vol. 31, Núm. 1, pp. 1-8

  3. Lipid nanoparticles as carriers for RNAi against viral infections: Current status and future perspectives

    BioMed Research International, Vol. 2014

2013

  1. Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis

    International Journal of Pharmaceutics, Vol. 454, Núm. 2, pp. 775-783

  2. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier

    Journal of Controlled Release, Vol. 166, Núm. 2, pp. 115-123

  3. Role of endocytic uptake in transfection efficiency of solid lipid nanoparticles-based nonviral vectors

    Journal of Gene Medicine, Vol. 15, Núm. 11-12, pp. 427-440

2012

  1. Dextran-protamine-solid lipid nanoparticles as a non-viral vector for gene therapy: In vitro characterization and in vivo transfection after intravenous administration to mice

    International Journal of Pharmaceutics, Vol. 425, Núm. 1-2, pp. 35-43

  2. Multicomponent nanoparticles as nonviral vectors for the treatment of fabry disease by gene therapy

    Drug Design, Development and Therapy, Vol. 6, pp. 303-310

2011

  1. Lipid nanoparticles as vehicles for macromolecules: Nucleic acids and peptides

    Recent Patents on Drug Delivery and Formulation, Vol. 5, Núm. 3, pp. 214-226

  2. Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: The importance of the entry pathway

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 79, Núm. 3, pp. 495-502

2010

  1. Solid lipid nanoparticles as potential tools for gene therapy: In vivo protein expression after intravenous administration

    International Journal of Pharmaceutics, Vol. 385, Núm. 1-2, pp. 157-162